Serum nitric oxide metabolite (NOx) levels in hypertensive patients at rest: A comparison of age, gender, blood pressure and complications using normotensive controls

Clinical and Experimental Pharmacology and Physiology

Volumn 34, Issue 8, 2007, Pages 725-731

  Higashino, Hideaki ^a,b   Miya, Hirohisa ^b   Mukai, Hidenori ^b   Miya, Yoshihisa ^b  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Higashi Yodogawa Hospital   (Japan)

Author keywords

Ageing; Gender; Hypertension; Nitric oxide metabolites; Serum NOx

Indexed keywords

ESTROGEN; NITRIC OXIDE;

ADULT; AGED; AGING; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CIRCULATION; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; ESTROGEN DEFICIENCY; FEMALE; GROUPS BY AGE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLITE; PERIPHERAL CIRCULATION; REST; SEX DIFFERENCE;

ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; BIOLOGICAL MARKERS; BLOOD PRESSURE; CASE-CONTROL STUDIES; COMORBIDITY; DIABETES MELLITUS; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; KIDNEY DISEASES; MALE; MIDDLE AGED; NITRATES; NITRIC OXIDE; NITRITES; SEX FACTORS;

EID: 34347330130     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2007.04617.x     Document Type: Article

References (24)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980 288 : 373 6.
2. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesise nitric oxide from l-arginine. Nature 1988 333 : 664 6.
3. Palmer RMJ, Rees DD, Ashton DS, Moncada S. l-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem. Biophys. Res. Commun. 1988 153 : 1251 6.
4. Föstermann U, Closs EI, Pollock JS et al. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning and functions. Hypertension 1994 23 : 1121 31.
5. Matsuda H, Hayashi K, Homma K et al. Differing anti-proteinuric action of candesartan and losartan in chronic renal disease. Hypertens. Res. 2003 26 : 875 80.
6. Li R, Lyn D, Lapu-Bula R et al. Relation of endothelial nitric oxide synthase gene to plasma nitric oxide level, endothelial function and blood pressure in African Americans. Am. J. Hypertens. 2004 17 : 560 7.
7. Matsubara T, Ishibashi T, Hori T et al. Association between coronary endothelial dysfunction and local inflammation of atherosclerotic coronary arteries. Mol. Cell. Biochem. 2003 249 : 67 73.
8. World Health Organization International Society of Hypertension Writing Group. World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J. Hypertens. 2003 21 : 1983 92.
9. Lyamina NP, Dolotovskaya PV, Lyamina SV, Malyshev IY, Manukhina EB. Nitric oxide production and intensity of free radical processes in young men with high normal and hypertensive blood pressure. Med. Sci. Monit. 2003 9 : CR304 10.
10. Takase H, Sugiyama M, Nakazawa A, Sato K, Dohi Y. Long-term effect of antihypertensive therapy with calcium antagonist or angiotensin-converting enzyme inhibitor on serum nitrite/nitrate levels in human essential hypertension. Arzneimittelforschung 2000 50 : 530 4.
11. Okamoto K, Yamori Y, Nagaoka A. Establishment of the stroke-prone spontaneously hypertensive rat (SHR). Circ. Res. 1974 34 3 5 (Suppl. 1 I 143 53.
12. Taddei S, Virdis A, Ghiadoni L, Versari D, Salvetti A. Endothelium, aging and hypertension. Curr. Hypertens. Rep. 2006 8 : 84 9.
13. Watanabe T, Akishita M, Toba K et al. Influence of sex and age on serum nitric/nitrate concentration in healthy subjects. Clin. Chim. Acta 2000 301 : 169 79.
14. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J. Clin. Invest. 1999 103 : 401 6.
15. Ishibashi T, Obayashi S, Sakamoto S et al. Estrogen replacement effectively improves the accelerated intimal hyperplasia following balloon injury of carotid artery in the ovariectomized rats. J. Cardiovasc. Pharmacol. 2006 47 : 37 45.
16. Maffei S, Mercuri A, Zucchelli GC, Vassalle C. Estrogen therapy effects on different vasoactive factors in recent postmenopausal healthy women. Int. J. Cardiol. 2006 107 : 194 9.
17. Sasaki K, Duan J, Murohara T et al. Rescue of hypercholesterolemia- related impairment of angiogenesis by oral folate supplementation. J. Am. Coll. Cardiol. 2003 42 : 364 72.
18. Minami M, Atarashi K, Ishiyama A, Hirata Y, Goto A, Omata M. Effects of cholesterol-lowering therapy on pressor hyperreactivity to stress in hypercholesterolemic patients. Hypertens. Res. 2003 26 : 373 80.
19. Tanaka S, Yashiro A, Nakashima Y, Nanri H, Ikeda M, Kuroiwa A. Plasma nitrite/nitrate level is inversely correlated with plasma low-density lipoprotein cholesterol level. Clin. Cardiol. 1997 20 : 361 5.
20. Balakhonova TV, Pogorelova OA, Susekov AV et al. Effect of atrovastatin on endothelial function in patients with familial hypercholesterolemia. Kardiologiia 2002 42 : 15 21.
21. Akarasereenout P, Nuamchit T, Thaworn A, Leowattana W, Chotewuttakorn S, Khunawat P. Serum nitric oxide levels in patients with coronary artery disease. J. Med. Assoc. Thai. 2001 84 (Suppl. 3 S730 9.
22. Ni Z, Vaziri ND. Downregulation of nitric oxide synthase in nephrotic syndrome: Role of proteinuria. Biochim. Biophys. Acta 2003 1638 : 129 37.
23. Thuraisingham RC, Yaqoob MM. Oxidative consumption of nitric oxide: A potential mediator of uremic vascular disease. Kidney Int. 2003 84 (S uppl S29 32.
24. Kim SW, Lee J, Paek YW, Kang DG, Choi KC. Decreased nitric oxide synthesis in rats with chronic renal failure. J. Korean Med. Sci. 2000 15 : 425 30.